Clinical Study (Ongoing)
The ongoing clinical study aims to demonstrate the diagnostic value of Spermosens’ technology. Successful results will provide the foundation for future partnerships and commercialization. The study is estimated to be completed by the end of 2025 with interim results being communicated on a regular basis.